EUVIMEDEUVIMED entdecken
Open Access

The 4-Aminomethylphenoxy-Benzoxaborole AN3057 as a Potential Treatment Option for Primary Amoebic Meningoencephalitis

Kateřina Ženíšková, Jan Mach iD, Dominik Arbon, Jan Štursa, Lukáš Werner, Martin Zoltner iD, Robert Sutak iD

Antimicrobial Agents and Chemotherapy · 2023

DOI: 10.1128/aac.01506-22 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Antimicrobial Agents and Chemotherapy, 2023. Verfasst von Kateřina Ženíšková und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Parasitology, Faculty of Science, Charles University, BIOCEV, Vestec, Czech Republic. Hauptthemen laut MEDLINE: Amebiasis, Central Nervous System Protozoal Infections, Naegleria fowleri, Meningoencephalitis. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Czech Science Foundation, Charles University Grant Agency, EC | European Regional Development Fund.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Primary amoebic meningoencephalitis is a rare but fatal central nervous system (CNS) disease caused by the “brain-eating amoeba” Naegleria fowleri . A major obstacle is the requirement for drugs with the ability to cross the blood-brain barrier, which are used in extremely high doses, cause severe side effects, and are usually ineffective.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AmebiasisCentral Nervous System Protozoal InfectionsNaegleria fowleriMeningoencephalitisAnimalsMiceBlood-Brain Barrier

Stichwörter der Autor:innen

Naegleria fowleriamoebaantiparasiticoxaboroleprimary amoebic meningoencephalitis

Autor:innen und Institutionen

  • Department of Parasitology, Faculty of Science, Charles University, BIOCEV, Vestec, Czech Republic.
  • Institute of Biotechnology, Czech Academy of Sciences, BIOCEV, Vestec, Czech Republic.

ORCID-Profile: Jan Mach, Martin Zoltner, Robert Sutak

Förderung

  • Czech Science Foundation
  • Charles University Grant Agency
  • EC | European Regional Development Fund
  • Czech Academy of Sciences
  • Gordon and Betty Moore Foundation

Zitieren

APA

Ženíšková, K., Mach, J., Arbon, D., Štursa, J., Werner, L., Zoltner, M., & Sutak, R. (2023). The 4-Aminomethylphenoxy-Benzoxaborole AN3057 as a Potential Treatment Option for Primary Amoebic Meningoencephalitis. Antimicrobial Agents and Chemotherapy. https://doi.org/10.1128/aac.01506-22

Vancouver

Ženíšková K, Mach J, Arbon D, Štursa J, Werner L, Zoltner M, et al. The 4-Aminomethylphenoxy-Benzoxaborole AN3057 as a Potential Treatment Option for Primary Amoebic Meningoencephalitis. Antimicrobial Agents and Chemotherapy. 2023. doi:10.1128/aac.01506-22

BibTeX
@article{enkov2023,
  author = {Ženíšková, Kateřina and Mach, Jan and Arbon, Dominik and Štursa, Jan and Werner, Lukáš and Zoltner, Martin and Sutak, Robert},
  title = {The 4-Aminomethylphenoxy-Benzoxaborole AN3057 as a Potential Treatment Option for Primary Amoebic Meningoencephalitis},
  journal = {Antimicrobial Agents and Chemotherapy},
  year = {2023},
  doi = {10.1128/aac.01506-22}
}
Kostenlos starten →